Dr. Thomas W. McLean
Claim this profileWake Forest University Health Sciences
Expert in Tumors
Expert in Brain Tumor
41 reported clinical trials
96 drugs studied
About Thomas W. McLean
Education:
- Obtained MD from Wake Forest University School of Medicine in 2008.
- Completed Residency in Internal Medicine at Wake Forest Baptist Medical Center in 2011.
- Finished Fellowship in Hematology and Oncology at Wake Forest Baptist Medical Center in 2014.
Experience:
- Currently serves as an Assistant Professor of Hematology and Oncology at Wake Forest School of Medicine.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Thomas W. McLean is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
More about Thomas W. McLean
Clinical Trial Related4 years of experience running clinical trials · Led 41 trials as a Principal Investigator · 23 Active Clinical TrialsTreatments Thomas W. McLean has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Doxorubicin Hydrochloride
- Methotrexate
- Vincristine Sulfate
Breakdown of trials Thomas W. McLean has run
Tumors
Brain Tumor
Lymphoma
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas W. McLean specialize in?
Thomas W. McLean focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Thomas W. McLean currently recruiting for clinical trials?
Yes, Thomas W. McLean is currently recruiting for 19 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Thomas W. McLean has studied deeply?
Yes, Thomas W. McLean has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Thomas W. McLean?
Apply for one of the trials that Thomas W. McLean is conducting.
What is the office address of Thomas W. McLean?
The office of Thomas W. McLean is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.